Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|10|7|849-862

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.7, 2011-01, pp. : 849-862

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P-gp Transporter and its Role in Neurodegenerative Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 2, 2009-02 ,pp. : 209-217

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Lipid Nanoparticles and its Surface Modification in Reaching the Brain: An Approach for Neurodegenerative Diseases Treatment

By  

Current Drug Delivery, Vol. 15, Iss. 9, 2018-11 ,pp. : 1218-1220

Bentham Science Publishers

Access to resources Recommend Favorite

A Role of GABA Analogues in the Treatment of Neurological Diseases

By  

Current Medicinal Chemistry, Vol. 17, Iss. 22, 2010-08 ,pp. : 2338-2347

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 2, 2008-04 ,pp. : 187-210

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Free Radicals in the Neurodegenerative Diseases: Therapeutic Implications for Antioxidant Treatment

By Halliwell B.  

Drugs & Aging, Vol. 18, Iss. 9, 2001-01 ,pp. : 685-716

Adis International

Access to resources Recommend Favorite